Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Actavis Group PTC ehf., Reykjavíkurvegi 76-78, 220 Hafnarfjörõur, Iceland
Lercanidipine hydrochloride 10 mg film-coated tablet.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Lercanidipine hydrochloride 10 mg film-coated tablet: Yellow, round, biconvex 6.5 mm film-coated tablets, scored on one side, marked ‘L’ on the other side. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. |
One film-coated tablet contains 10 mg lercanidipine hydrochloride, equivalent to 9.4mg lercanidipine.
Excipient with known effect: Lercanidipine hydrochloride 10 mg film-coated tablet: Lactose monohydrate 30 mg
For the full list of excipients, see section 6.1.
| List of Excipients |
|---|
|
Tablet core: Magnesium stearate Film-coating: Lercanidipine 10 mg film-coated tablets: Macrogol |
Blister pack (Aluminium/PVC/PVDC) with push-through foil.
Tablet container (HDPE), closed with a sealed LDPE-cap.
Blister (AL/PVC/PVDC):
Lercanidipine hydrochloride 10 mg film-coated tablets: 14, 20, 28, 30, 50, 56, 60, 90, 98, 100 film-coated tablets.
Tablet containers:
Lercanidipine hydrochloride 10 mg film-coated tablets: 100 film-coated tablets.
Actavis Group PTC ehf., Reykjavíkurvegi 76-78, 220 Hafnarfjörõur, Iceland
PL30306/0136
19.06.2009/24.09.2014
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
